Trials / Completed
CompletedNCT04482049
A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders
A Prospective, Multicenter, Non-interventional Study to Investigate the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders (FAOD)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 61 (actual)
- Sponsor
- Reneo Pharma Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to collect information on disease characteristics from adult patients diagnosed with fatty acid oxidation disorders (FAOD).
Detailed description
In this study there will be no drug intervention. The study will include a Baseline visit and a follow up visit scheduled at Month 4. At these visits medical history, safety assessments, concomitant medications, exercise tests and quality of life questionnaire data will be collected.
Conditions
Timeline
- Start date
- 2021-01-15
- Primary completion
- 2022-05-04
- Completion
- 2022-05-04
- First posted
- 2020-07-22
- Last updated
- 2023-11-18
Locations
15 sites across 11 countries: United States, Austria, Belgium, Czechia, Denmark, France, Hungary, Italy, Poland, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT04482049. Inclusion in this directory is not an endorsement.